IndraLab

Statements


USP22 inhibits IKBKB. 2 / 2
| 2

reach
"They show that three USPs -- USP14, USP18, and USP22 -- fulfilled these criteria, but focused on USP14, as USP18 and USP22 could also inhibit IKKbeta activation directly in the absence of NLRC5."

reach
"Importantly, we observed that USP18 and USP22, but not USP14, may directly inhibit IKK-beta activation through an NLRC5 independent mechanism."